18 embedded-system "https:" "https:" "https:" "https:" "Kiel University" PhD scholarships at UCL
Sort by
Refine Your Search
-
About the Project A fully funded PhD scholarship is available at UCL Electronic & Electrical Engineering (4 years, home tuition fees covered, stipend provided). Exceptional international candidates
-
synthesis and formulation platforms, the project will generate and screen a diverse library of polymers optimised for mucosal delivery. The resulting delivery systems could enable next-generation vaccines
-
. Interested candidates may want to take a look at our recent work on machine learning molecular dynamics: https://www.nature.com/articles/s41467-024-52491-3 Project 2: Non-adiabatic Molecular Dynamics
-
with the RFC1 repeat expansions is heterogeneous, in terms of age at onset, disease course, neurological involvement. However, determinants of the variability of RFC1 disease are still largely unknown
-
Supervisors: Dr. Maximilian Besenhard Dr. Maryam Parhizkar Abstract: Antimicrobial peptides (AMPs) are natural molecules produced by the immune system and represent one of the most promising avenues
-
challenging. This project aims to develop an ultrasound-assisted nanoparticle-based drug delivery system for targeted, controlled release of antimicrobials within these hard-to-reach oral microenvironments. By
-
Supervisors: Dr. Duygu Dikicioglu Prof. Eli Keshavarz-Moore Abstract: Antifungal resistance is a growing and under-recognised global health threat. Fungal infections affect over a billion people
-
The student will work across UCL Mechanical Engineering and RNOH, benefiting from a collaborative environment and access to state-of-the-art facilities. Research Environment: The project is hosted in
-
Supervisors: Dr Darren N. Nesbeth Prof Eli Keshavarz-Moore Abstract: Horizontal gene transfer via conjugative plasmids is a major but underexploited driver of antimicrobial resistance (AMR) spread
-
. Synthetic analogues will be developed and screened alone and in combination with existing antimicrobials. The ultimate goal is to design novel chemotherapeutic combinations that disrupt cell wall remodelling